Back to Journals » Clinical Pharmacology: Advances and Applications
Clinical Pharmacology: Advances and Applications
ISSN: 1179-1438
- View all (260)
- Volume 15, 2023 (5)
- Volume 14, 2022 (12)
- Volume 13, 2021 (27)
- Volume 12, 2020 (28)
- Volume 11, 2019 (16)
- Volume 10, 2018 (19)
- Volume 9, 2017 (19)
- Volume 8, 2016 (20)
- Volume 7, 2015 (14)
- Volume 6, 2014 (23)
- Volume 5, 2013 (30)
- Volume 4, 2012 (11)
- Volume 3, 2011 (7)
- Volume 2, 2010 (28)
- Volume 1, 2009 (1)
Journal Articles:
- 260 records -
Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus
Nomura S, Shouzu A, Taniura T, Okuda Y, Omoto S, Suzuki M, Ito T, Toyoda N
Clinical Pharmacology: Advances and Applications 2023, 15:41-55
Published Date: 25 May 2023
Cefepime-Induced Neutropenia: A Case Report and Literature Review
Koraysh S, Koleri J, Ali M
Clinical Pharmacology: Advances and Applications 2023, 15:33-40
Published Date: 19 April 2023

Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults
Yihunie W, Kebede B, Tegegne BA, Getachew M, Abebe D, Aschale Y, Belew H, Bahiru B
Clinical Pharmacology: Advances and Applications 2023, 15:21-32
Published Date: 14 March 2023

A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects
Cheng Y, Ye Y, Gaudy A, Ghosh A, Xue Y, Wang A, Zhou S, Li Y
Clinical Pharmacology: Advances and Applications 2023, 15:9-19
Published Date: 28 February 2023

Chemical versus Mechanical and Chemical Venous Thromboembolism Prophylaxis in Neurocritically Ill Patients: A Cohort Study
Alshaya AI, Alyahya H, Alzoman R, Faden R, Alshaya OA, Al Sulaiman K, Alanazi F, Aldekhyl S
Clinical Pharmacology: Advances and Applications 2023, 15:1-8
Published Date: 7 January 2023

Anti-Diarrheal Activities of Hydromethanolic Crude Extract and Solvent Fractions of Acacia seyal (Fabaceae) Roots in Mice [Response to Letter]
Mengesha AK, Birru EM, Adugna M
Clinical Pharmacology: Advances and Applications 2022, 14:113-114
Published Date: 8 December 2022

A Response to Article “Anti-Diarrheal Activity of Hydromethanolic Crude Extract and Solvent Fractions of Acacia Seyal (Fabaceae) Roots in Mice” [Letter]
Panjaitan NSD, Fitriana F, Handayani S
Clinical Pharmacology: Advances and Applications 2022, 14:111-112
Published Date: 29 November 2022

Anti-Diarrheal Activities of Hydromethanolic Crude Extract and Solvent Fractions of Acacia seyal (Fabaceae) Roots in Mice
Mengesha AK, Birru EM, Adugna M
Clinical Pharmacology: Advances and Applications 2022, 14:99-110
Published Date: 15 November 2022

Fidaxomicin Use in the Pediatric Population with Clostridioides difficile
Oliver MB, Vaughn BP
Clinical Pharmacology: Advances and Applications 2022, 14:91-98
Published Date: 23 September 2022

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response
Stefanovic F, Gomez-Caminero A, Jacobs DM, Subramanian P, Puzanov I, Chilbert MR, Feuerstein SG, Yatsynovich Y, Switzer B, Schentag JJ
Clinical Pharmacology: Advances and Applications 2022, 14:69-90
Published Date: 10 August 2022

Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
Alorfi NM, Algarni AS
Clinical Pharmacology: Advances and Applications 2022, 14:61-67
Published Date: 3 August 2022

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
Kosmas CE, Bousvarou MD, Sourlas A, Papakonstantinou EJ, Peña Genao E, Echavarria Uceta R, Guzman E
Clinical Pharmacology: Advances and Applications 2022, 14:49-59
Published Date: 16 July 2022


Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019


Ahmedalgabri RHM, Omer T, Zarroug F, Elkhawad AO, Noma M
Clinical Pharmacology: Advances and Applications 2022, 14:37-47
Published Date: 5 April 2022

Evaluating Pharmacists’ Pharmacological Knowledge and Views Regarding Pfizer-BioNTech COVID-19 Vaccine in Saudi Arabia
Alorfi N, Ashour A
Clinical Pharmacology: Advances and Applications 2022, 14:27-35
Published Date: 5 April 2022

Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
Inaishi J, Saisho Y
Clinical Pharmacology: Advances and Applications 2022, 14:19-26
Published Date: 21 February 2022

Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A Review
Zewdie KA, Hailu HG, Ayza MA, Tesfaye BA
Clinical Pharmacology: Advances and Applications 2022, 14:11-17
Published Date: 21 February 2022

Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on Brigatinib
Rijavec E, Biello F, Indini A, Grossi F, Genova C
Clinical Pharmacology: Advances and Applications 2022, 14:1-9
Published Date: 20 January 2022

Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience

Roshmi RR, Yokota T
Clinical Pharmacology: Advances and Applications 2021, 13:235-242
Published Date: 16 December 2021

Potential of Quinine Sulfate for COVID-19 Treatment and Its Safety Profile: Review
Latarissa IR, Barliana MI, Meiliana A, Lestari K
Clinical Pharmacology: Advances and Applications 2021, 13:225-234
Published Date: 6 December 2021

Pharmacological Management of Urinary Incontinence: Current and Emerging Treatment
Gandi C, Sacco E
Clinical Pharmacology: Advances and Applications 2021, 13:209-223
Published Date: 25 November 2021

A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent
Murray R, Tobias JT
Clinical Pharmacology: Advances and Applications 2021, 13:203-207
Published Date: 18 October 2021

Comparing the Efficacy of a Nurse-Driven and a Physician-Driven Diabetic Ketoacidosis (DKA) Treatment Protocol
Anis TR, Boudreau M, Thornton T
Clinical Pharmacology: Advances and Applications 2021, 13:197-202
Published Date: 7 October 2021

Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19
Panda PK, Singh BO, Moirangthem B, Bahurupi YA, Saha S, Saini G, Dhar M, Bairwa M, Pai VS, Agarwal A, Sindhwani G, Handu S, Kant R
Clinical Pharmacology: Advances and Applications 2021, 13:185-195
Published Date: 29 September 2021

Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban
Anis TR, Jandreau W
Clinical Pharmacology: Advances and Applications 2021, 13:181-184
Published Date: 29 September 2021

Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor
Joseph NS, Tai YT, Anderson KC, Lonial S
Clinical Pharmacology: Advances and Applications 2021, 13:169-180
Published Date: 18 August 2021

Evaluation of Antimalarial Activity of 80% Methanolic Root Extract of Dorstenia barnimiana Against Plasmodium berghei–Infected Mice
Derebe D, Wubetu M, Alamirew A
Clinical Pharmacology: Advances and Applications 2021, 13:157-167
Published Date: 16 July 2021

Evaluation of the Pharmacokinetics of Trazpiroben (TAK-906), a Peripherally Selective D2/D3 Dopamine Receptor Antagonist, in the Presence and Absence of Itraconazole, a Potent CYP 3A4 Inhibitor
Chen C, Zhang W, Bari M, Almansa C, Baratta M, Rosario M
Clinical Pharmacology: Advances and Applications 2021, 13:145-155
Published Date: 12 July 2021

Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective
Yamamoto T
Clinical Pharmacology: Advances and Applications 2021, 13:135-143
Published Date: 23 June 2021

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study
Gordon D, Hellriegel ET, Hope HR, Burt D, Monahan JB
Clinical Pharmacology: Advances and Applications 2021, 13:123-134
Published Date: 10 June 2021

Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study
Santamaria E, Izquierdo I, Valle M
Clinical Pharmacology: Advances and Applications 2021, 13:115-122
Published Date: 8 June 2021

Determination of Caffeine and Hydrogen Peroxide Antioxidant Activity of Raw and Roasted Coffee Beans Around Habru Woreda, Ethiopia Using UV-Vis Spectroscopy
Legas Muhammed B, Hussen Seid M, Habte AT
Clinical Pharmacology: Advances and Applications 2021, 13:101-113
Published Date: 24 May 2021

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain
Thanawala S, Shah R, Somepalli V, Alluri KV, Desomayanandam P, Bhuvanendran A
Clinical Pharmacology: Advances and Applications 2021, 13:91-100
Published Date: 21 May 2021

Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant Bacteria
Masadeh MM, Alzoubi KH, Masadeh MM, Aburashed ZO
Clinical Pharmacology: Advances and Applications 2021, 13:83-90
Published Date: 11 May 2021

An Investigator-Initiated, Prospective, Single-Center, Open-Label Clinical Study to Evaluate Safety and Performance of Intra-Articular Hyaluronic Acid (IA-HA) (Biovisc Ortho) in Patients with Osteoarthritis (OA) of the Knee
Gupta A, Channaveera C, Anand V, Sethi S
Clinical Pharmacology: Advances and Applications 2021, 13:73-82
Published Date: 11 May 2021
Population Pharmacokinetics of CC-122
Cheng Y, Chen J, Pourdehnad M, Zhou S, Li Y
Clinical Pharmacology: Advances and Applications 2021, 13:61-71
Published Date: 28 April 2021

Clinical Impact of Liraglutide as a Treatment of Obesity
Alruwaili H, Dehestani B, le Roux CW
Clinical Pharmacology: Advances and Applications 2021, 13:53-60
Published Date: 11 March 2021

Efficacy of Generic Atorvastatin in a Real-World Setting
Manasirisuk P, Chainirun N, Tiamkao S, Lertsinudom S, Phunikhom K, Sawunyavisuth B, Sawanyawisuth K
Clinical Pharmacology: Advances and Applications 2021, 13:45-51
Published Date: 5 March 2021
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2021, 13:43-44
Published Date: 3 March 2021
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2021, 13:41-42
Published Date: 3 March 2021
Administration of Supplemental L-Tyrosine with Phenelzine: a Clinical Literature Review [Retraction]
Hinz M, Stein A, Cole T, Ryan P
Clinical Pharmacology: Advances and Applications 2021, 13:39-40
Published Date: 3 March 2021
Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion
Rouland A, Bouillet B, Legris P, Simoneau I, Petit JM, Vergès B
Clinical Pharmacology: Advances and Applications 2021, 13:33-37
Published Date: 5 February 2021

Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials
Vermunt M, Marchetti S, Beijnen J
Clinical Pharmacology: Advances and Applications 2021, 13:21-32
Published Date: 27 January 2021

Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
Turner R, Wevrett SR, Edmunds S, Brown MB, Kulasekaran A, Adegoke O, Farrah J
Clinical Pharmacology: Advances and Applications 2021, 13:13-20
Published Date: 19 January 2021

The Impact of First-Line Anti-Tubercular Drugs’ Pharmacokinetics on Treatment Outcome: A Systematic Review
Sileshi T, Tadesse E, Makonnen E, Aklillu E
Clinical Pharmacology: Advances and Applications 2021, 13:1-12
Published Date: 12 January 2021

Wound Healing Effect of Acokanthera schimperi Schweinf (Apocynaceae) Methanol Leaf Extract Ointment in Mice and Its in-vitro Antioxidant Activity
Alemu BK, Misganaw D, Mengistu G
Clinical Pharmacology: Advances and Applications 2020, 12:213-222
Published Date: 31 December 2020

An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease
Mulaw Belete T
Clinical Pharmacology: Advances and Applications 2020, 12:203-212
Published Date: 14 December 2020

Safety and Tolerability of PCSK9 Inhibitors: Current Insights
Kosmas CE, Skavdis A, Sourlas A, Papakonstantinou EJ, Peña Genao E, Echavarria Uceta R, Guzman E
Clinical Pharmacology: Advances and Applications 2020, 12:191-202
Published Date: 11 December 2020
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]
Liao MZ, Kast J, Berkhout M, Prenen H, Dutta S, Upreti VV
Clinical Pharmacology: Advances and Applications 2020, 12:189-190
Published Date: 9 December 2020
Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia
Kumsa A, Girma S, Alemu B, Agenagnew L
Clinical Pharmacology: Advances and Applications 2020, 12:179-187
Published Date: 1 December 2020
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]
Hendrikx JJMA, Beijnen JH, Huitema ADR
Clinical Pharmacology: Advances and Applications 2020, 12:177-178
Published Date: 30 October 2020